Which Merck ETF Best Balances Its Drug Upside And Risks?
Owning Merck stock outright means you feel every bump in its specific issues yourself. Simply Wall St flags that Merck’s profit margins of 3.6% are far lower than last year’s 29.6%, and it notes the risk that blockbuster cancer drug exclusivity eventually fades. An exchange traded fund that owns Merck alongside dozens of other healthcare businesses mutes how much those Merck specific swings move your total portfolio, and tempers any upside from the stock at the same time. Today’s news is a...

What's Your Reaction?









